Experience with cryopreserved cadaveric femoral vein allografts used for hemodialysis access

Annals of Vascular Surgery

Volumn 18, Issue 4, 2004, Pages 453-458

  Madden, Robert L ^a,b,c   Lipkowitz, George S ^a,b   Browne, Barry J ^a,b   Kurbanov, Alexander ^a,b  

^a BAYSTATE MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLITEF;

ANEURYSM; ARTERY STEAL SYNDROME; ARTICLE; CADAVER; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CRYOPRESERVATION; FEMORAL VEIN ALLOGRAFT; FISTULA; GRAFT PATENCY; HEMODIALYSIS; HUMAN; INFECTION; MONITORING; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; SYSTEMATIC REVIEW; THROMBOSIS; VASCULAR ACCESS; VEIN GRAFT;

EID: 3543024458     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10016-004-0055-0     Document Type: Article

References (14)

1. Beathard GA. Improving dialysis vascular access. Dialysis Transplant 2002;31:210-219.
2. Schwab SJ. Improving access patency: pre-end-stage renal disease strategies. J. Am. Soc. Nephrol. 1998;9:S124-129.
3. Gibson KD, Gillen DL, Caps MT, et al. Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System dialysis morbidity and mortality study. J. Vasc. Surg. 2001;34:694-700.
4. Lin PH, Brinkman WT, Terramani TT, et al. Management of infected hemodialysis access grafts using cryopreserved human vein allografts. Am. J. Surg. 2002;184:31-36.
5. Miller PE, Carlton D, Deierhoi MH, et al. Natural history of arteriovenous grafts in hemodialysis patients. Am. J. Kidney Dis. 2000;36:68-74.
6. Madden R, Lipkowitz G, Benedetto B, et al. Decellularized cadaver vein allografts used for hemodialysis access do not cause allosensitization or preclude kidney transplantation. Am. J. Kidney Dis. 2002;40:1240-1243.
7. Matsuura JH, Rosenthal D, Wellons ED, Castronovo CS, Fronk D. Hemodialysis graft infections treated with cryopreserved femoral vein. Cardiovasc. Surg. 2002;10:561-565.
8. Bolton WD, Cull DL, Taylor SM, et al. The use of cryopreserved femoral vein grafts for heamodialysis access in patients at high risk for infection: a word of caution. J. Vasc. Surg. 2002;36:464-468.
9. Sidawy AN, Gray R, Besarab A, et al. Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J. Vasc. Surg. 2002;35:603-610.
10. Clinical Program 301: allograft veins protocol. CryoLife Inc. Full reference available on request from CryoLife..
11. Martin RS, Edwards WH, Mulherin JL, et al. Cryopreserved saphenous vein allografts for below-knee lower extremity revascularization. Ann. Surg. 1994;219:664-672.
12. Iaffaldano RA, Lewis BE, Johnson SA, et al. Patency of cryopreserved saphenous vein grafts as conduits for coronary artery bypass surgery. Chest 1995;108:725-729.
13. Benedetto B, Lipkowitz G, Madden R, et al. Use of cryopreserved cadaveric vein alograft for hemodialysis access precludes kidney transplantation because of allosensitization. J. Vasc. Surg. 2001;34:139-142.
14. Oliver MJ, McCann RL, Indridason OS, et al. Comparison of transposed brachiobasilic fistulas to upper arm grafts and brachiocephalic fistulas. Kidney Int. 2001;60:1532-1539.